We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathway Outlined that Regulates Centrosome Disassociation During Cell Division

By LabMedica International staff writers
Posted on 08 Dec 2010
The detailed structure of a molecular pathway controlling the disassociation of the centrosome during cell division has been revealed in a recent publication.

During interphase, centrosomes are held together by a proteinaceous linker that connects the proximal ends of the mother and daughter centrioles. This linker is disassembled at the onset of mitosis in a process known as centrosome disjunction, thereby facilitating centrosome separation and bipolar spindle formation. An enzyme known as NIMA (never in mitosis A)-related kinase or Nek2A has been implicated in disconnecting the centrosomes through disjoining the linker proteins C-Nap1 and rootletin. However, the mechanisms controlling centrosome disjunction have remained poorly understood.

In the current study, which appeared in the November 14, 2010, online edition of the journal Nature Cell Biology, investigators at the University of Heidelberg (Germany) and the University of Leicester (United Kingdom) explained how Nek2A directly interacted with two Hippo pathway components, the mammalian sterile 20-like kinase 2 (Mst2) and the scaffold protein Salvador (hSav1). This interaction regulated the ability of Nek2A to localize to centrosomes and phosphorylate the linker proteins C-Nap1 and rootletin.

Contributing author Dr. Andrew Fry, professor of biochemistry at the University of Leicester, said, "This is an exciting new development that offers potential for finding new ways of inhibiting unregulated cell division which is a characteristic of cancer. Our research has identified new proteins that control centrosome separation as well as assessing the relative contributions of these together with previously described regulators. Importantly, this work suggests exciting new approaches to the targeted treatment of diseases characterized by deregulated cell division, such as cancer, as inhibitors of centrosome separation have the potential to prevent uncontrolled cell proliferation.”

Related Links:
University of Heidelberg
University of Leicester



New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Multi-Chamber Washer-Disinfector
WD 390

Latest BioResearch News

Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
08 Dec 2010  |   BioResearch

Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
08 Dec 2010  |   BioResearch

Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
08 Dec 2010  |   BioResearch